nsclc: podcasts

Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.

1. 1▶IberdomideOncoPharm15:37Notes
   +Listen later
2. 2▶LCC: Grace Under Pressure: Navigating Burnout and Loss in OncologyLung Cancer Considered47:14Notes
   +Listen later
3. 3▶LCC Advances in ALK+ Cancer in CantoneseLung Cancer Considered46:26Notes
   +Listen later
4. 4▶Kidney Cancer in a NutshellOncoPharm16:12Notes
   +Listen later
5. 5▶Small Cell Lung Cancer and CINV UpdatesOncoPharm17:35Notes
   +Listen later
6. 6▶Treating Advanced Thymic CancersLung Cancer Considered59:23Notes
   +Listen later
7. 7▶Zidesamtinib & PPIs in PacificOncoPharm16:32Notes
   +Listen later
8. 8▶FDA Approval: Zidesamtinib and ROS1 NSCLCLung Cancer Considered24:01Notes
   +Listen later
9. 9▶Gedatolisib et alOncoPharm18:16Notes
   +Listen later
10. 10▶Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung CancerLung Cancer Considered47:39Notes
    +Listen later
11. 11▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Heart & Lung Audio16:39Notes
    +Listen later
12. 12▶Endurance Part 2OncoPharm15:12Notes
    +Listen later
13. 13▶A Decade of CAR-T, Ocra-T, & POLARGOOncoPharm19:18Notes
    +Listen later
14. 14▶IASLC - Your First Faculty JobLung Cancer Considered41:58Notes
    +Listen later
15. 15▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Heart & Lung Audio1:17:14Notes
    +Listen later
16. 16▶Breast Cancer Updates and T-Cell StemnessOncoPharm19:23Notes
    +Listen later
17. 17▶Game Changers & Hard Truths: Dr. Balazs Halmos UnfilteredLung Cancer Considered45:54Notes
    +Listen later
18. 18▶Updates on capivasertib, belzutifan, talquetamab, & durvalumabOncoPharm19:32Notes
    +Listen later
19. 19▶Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) PreviewLung Cancer Considered39:16Notes
    +Listen later
20. 20▶ASCO '26OncoPharm25:38Notes
    +Listen later
21. 21▶ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung CancerLung Cancer Considered40:18Notes
    +Listen later
22. 22▶ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted TherapyLung Cancer Considered45:54Notes
    +Listen later
23. 23▶Anjali Tiku Owens, MD - Contemporary Data, Differentiation, and Decision-Making in Hypertrophic Cardiomyopathy: A Guide to Cardiac Myosin Inhibition for the Managed Care ProfessionalPeerVoice Heart & Lung Audio1:20:09Notes
    +Listen later
24. 24▶Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Heart & Lung Audio36:53Notes
    +Listen later
25. 25▶Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy EraPeerVoice Heart & Lung Audio40:01Notes
    +Listen later
26. 26▶Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established TherapiesPeerVoice Heart & Lung Audio21:52Notes
    +Listen later
27. 27▶Ira Goldberg, MD - Mastering the Fundamentals of Care for Chylomicronemia: Following the Patient Care Pathway From Differential Diagnosis to Modern ManagementPeerVoice Heart & Lung Audio29:06Notes
    +Listen later
28. 28▶Ira Goldberg, MD - The Expanding Treatment Landscape for Familial Chylomicronemia Syndrome: Exploring New Options and OpportunitiesPeerVoice Heart & Lung Audio9:49Notes
    +Listen later
29. 29▶John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient OutcomesPeerVoice Heart & Lung Audio30:19Notes
    +Listen later
30. 30▶Erwan Donal, MD, PhD / Nina Ajmone Marsan, MD, PhD - At the Cutting Edge of ATTR-CM: How Can We Leverage Advances in Multimodality Cardiac Imaging and Artificial Intelligence to Modernise Diagnosis and Monitoring?PeerVoice Heart & Lung Audio29:14Notes
    +Listen later